Works matching DE "ERIBULIN"

Results: 280
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25769-z
    By:
    • Keenan, Tanya E.;
    • Guerriero, Jennifer L.;
    • Barroso-Sousa, Romualdo;
    • Li, Tianyu;
    • O'Meara, Tess;
    • Giobbie-Hurder, Anita;
    • Tayob, Nabihah;
    • Hu, Jiani;
    • Severgnini, Mariano;
    • Agudo, Judith;
    • Vaz-Luis, Ines;
    • Anderson, Leilani;
    • Attaya, Victoria;
    • Park, Jihye;
    • Conway, Jake;
    • He, Meng Xiao;
    • Reardon, Brendan;
    • Shannon, Erin;
    • Wulf, Gerburg;
    • Spring, Laura M.
    Publication type:
    Article
    25

    Correction.

    Published in:
    2021
    Publication type:
    Correction Notice
    26

    An economic evaluation of eribulin for advanced breast cancer treatment based on the Southeast Netherlands advanced breast cancer registry.

    Published in:
    Acta Oncologica, 2020, v. 59, n. 9, p. 1123, doi. 10.1080/0284186X.2020.1775289
    By:
    • Pouwels, Xavier G. L. V.;
    • Ramaekers, Bram L. T.;
    • Geurts, Sandra M. E.;
    • Erdkamp, Frans;
    • Vriens, Birgit E. P. J.;
    • Aaldering, Kirsten N. A.;
    • van de Wouw, Agnes J.;
    • Dercksen, M. W.;
    • Smilde, Tineke J.;
    • Peters, Natascha A. J. B.;
    • van Riel, J. M. G. H.;
    • Pepels, Manon J.;
    • Heijnen-Mommers, Jose;
    • Tjan-Heijnen, Vivianne C. G.;
    • de Boer, Maaike;
    • Joore, Manuela A.
    Publication type:
    Article
    27

    The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry.

    Published in:
    Acta Oncologica, 2020, v. 59, n. 1, p. 82, doi. 10.1080/0284186X.2019.1670356
    By:
    • Pouwels, X. G. L. V.;
    • Geurts, S. M. E.;
    • Ramaekers, B. L. T.;
    • Erdkamp, F.;
    • Vriens, B. E. P. J.;
    • Aaldering, K. N. A.;
    • van de Wouw, A. J.;
    • Dercksen, M. W.;
    • Smilde, T. J.;
    • Peters, N. A. J. B.;
    • Riel, J. M. van;
    • Pepels, M. J.;
    • Heijnen-Mommers, J.;
    • Joore, M. A.;
    • Tjan-Heijnen, V. C. G.;
    • de Boer, M.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Effectiveness and safety of eribulin for human epidermal growth factor receptor 2 negative metastatic breast cancer in a real-world population.

    Published in:
    Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 7, p. 1573, doi. 10.1177/10781552211038241
    By:
    • Díaz-Acedo, Rocío;
    • Artacho Criado, Silvia;
    • Jiménez Galán, Rocío;
    • Gutiérrez Pizarraya, Antonio;
    • Galván Banqueri, Mercedes;
    • Rodríguez-de-la-Borbolla-Artacho, María;
    • Marcos Rodríguez, José Antonio;
    • Márquez Saavedra, Esther
    Publication type:
    Article
    39
    40
    41
    42
    43
    44

    Erratum.

    Published in:
    2018
    Publication type:
    Correction Notice
    45
    46
    47
    48
    49
    50